Abstract
Cholescintigraphy with 99mTc-hepatobiliary radiopharmaceuticals has been an important, clinically useful diagnostic imaging study for almost 4 decades. It continues to be in much clinical demand; however, the indications, methodology, and interpretative criteria have evolved over the years. This review will emphasize state-of-the-art methodology and diagnostic criteria for various clinical indications, including acute cholecystitis, chronic acalculous gallbladder disease, high-grade and partial biliary obstruction, and the postcholecystectomy pain syndrome, including sphincter-of-Oddi dysfunction and biliary atresia. The review will also emphasize the use of diagnostic pharmacologic interventions, particularly sincalide.
Original language | English (US) |
---|---|
Pages (from-to) | 967-975 |
Number of pages | 9 |
Journal | Journal of Nuclear Medicine |
Volume | 55 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2014 |
Keywords
- Acute cholecystitis
- Biliary dyskinesia
- Cholescintigraphy
- Chronic acalculous gallbladder disease
- Chronic cholecystitis
- Hepatobiliary scintigraphy
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging